AI is speeding up B2B buying without making decisions easier. Buyers move through early research faster and with less vendor contact. Marketers need clear, specific, consistent information across touchpoints—or risk losing ground in evaluation.
When streaming services feel alike, price hikes or removed content can lose subscribers, upending media plans.
Meta's new genAI tools speed production and improve performance, but consumer trust still challenges payoff.
Cuts at Meta, Epic, and Sony recast immersive bets around monetizable user-generated content and cross-platform assets.
A verdict that their feed designs are addictive could yield warnings to users, tighter ad rules, and legal reforms.
73% of consumers shun brands near misinformation—yet media dollars still flow there unchecked.
The jury is still out on whether customers will care.
Once buzzy enough to stall a Tyler Perry studio, Sora fades as OpenAI chases enterprise tools, ending its Disney licensing deal.
Claude’s new pilot now clicks and types in apps, yet audit gaps mean brands must govern use tightly.
Three-minute, structured tracks make AI music viable for ads—if brands avoid sameness.
After mass layoffs, AWS rolls out AI agents to answer tech queries and sync partners, tying automation directly to revenue efficiency.
75% use genAI, yet tangled workflows and data silos still stall real decisions.
We’re tracking how these effects are unfolding across industries and how those consequences shift based on companies’ exposure to three key regions: North America, Europe, and the Middle East and Asia.
Many AI users change appointments, health habits, and medications after engaging with an AI tool. Health brands need content built for AI discovery.
Launch screen takeover and sequencing ads mimic TV roadblocks, trading seamless feed vibes for recall and control.
Expanding Apple’s ad play beyond the App Store risks degrading its low-commercial user experience.
Publicis dominated 2025 new business with $10 billion in wins and slim losses, widening the gap as competitors like WPP stumbled.
Doctronic branding itself as an “AI doctor” will trigger tougher regulatory oversight.